Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1975 1
2007 1
2008 2
2009 5
2010 5
2011 3
2012 6
2013 9
2014 15
2015 17
2016 17
2017 18
2018 12
2019 10
2020 14
2021 17
2022 14
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

129 results
Results by year
Filters applied: . Clear all
Page 1
Selexipag for the treatment of chronic thromboembolic pulmonary hypertension.
Ogo T, Shimokawahara H, Kinoshita H, Sakao S, Abe K, Matoba S, Motoki H, Takama N, Ako J, Ikeda Y, Joho S, Maki H, Saeki T, Sugano T, Tsujino I, Yoshioka K, Shiota N, Tanaka S, Yamamoto C, Tanabe N, Tatsumi K; Study Group. Ogo T, et al. Among authors: motoki h. Eur Respir J. 2022 Jul 7;60(1):2101694. doi: 10.1183/13993003.01694-2021. Print 2022 Jul. Eur Respir J. 2022. PMID: 34824052 Free PMC article. Clinical Trial.
Rationale and design of the EMPYREAN study.
Motoki H, Masuda I, Yasuno S, Oba K, Shoin W, Usami S, Saito Y, Waki M, Komatsu M, Ueshima K, Nakagawa Y, Son C, Yonemitsu S, Hiramitsu S, Konda M, Onishi K, Kuwahara K. Motoki H, et al. ESC Heart Fail. 2020 Oct;7(5):3134-3141. doi: 10.1002/ehf2.12825. Epub 2020 Jun 23. ESC Heart Fail. 2020. PMID: 32578353 Free PMC article. Clinical Trial.
NRSF-GNAO1 Pathway Contributes to the Regulation of Cardiac Ca2+ Homeostasis.
Inazumi H, Kuwahara K, Nakagawa Y, Kuwabara Y, Numaga-Tomita T, Kashihara T, Nakada T, Kurebayashi N, Oya M, Nonaka M, Sugihara M, Kinoshita H, Moriuchi K, Yanagisawa H, Nishikimi T, Motoki H, Yamada M, Morimoto S, Otsu K, Mortensen RM, Nakao K, Kimura T. Inazumi H, et al. Among authors: motoki h. Circ Res. 2022 Jan 21;130(2):234-248. doi: 10.1161/CIRCRESAHA.121.318898. Epub 2021 Dec 8. Circ Res. 2022. PMID: 34875852
"Alpha"-Looped Broken Pacemaker Lead Inside the Heart.
Tabata H, Okada A, Kobayashi H, Shoin W, Okano T, Yoshie K, Motoki H, Shoda M, Kuwahara K. Tabata H, et al. Among authors: motoki h. Circ J. 2020 Dec 25;85(1):77. doi: 10.1253/circj.CJ-20-0680. Epub 2020 Oct 30. Circ J. 2020. PMID: 33132229 Free article. No abstract available.
Identification of metabolomic profile related to adult Fontan pathophysiology.
Motoki N, Motoki H, Utsumi M, Yamazaki S, Obinata H, Takei K, Yasukochi S. Motoki N, et al. Among authors: motoki h. Int J Cardiol Heart Vasc. 2021 Nov 24;37:100921. doi: 10.1016/j.ijcha.2021.100921. eCollection 2021 Dec. Int J Cardiol Heart Vasc. 2021. PMID: 34901379 Free PMC article.
Impact of Frailty and Age on Clinical Outcomes in Patients Who Underwent Endovascular Therapy.
Nishikawa K, Ebisawa S, Miura T, Kato T, Yusuke K, Abe N, Yokota D, Yanagisawa T, Senda K, Wakabayashi T, Oyama Y, Karube K, Itagaki T, Yui H, Maruyama S, Nagae A, Sakai T, Okina Y, Nakazawa S, Tsukada S, Saigusa T, Okada A, Motoki H, Kagoshima M, Kuwahara K. Nishikawa K, et al. Among authors: motoki h. J Endovasc Ther. 2022 Dec;29(6):845-854. doi: 10.1177/15266028211067729. Epub 2021 Dec 30. J Endovasc Ther. 2022. PMID: 34969317
JCS 2022 Guideline on Management and Re-Interventional Therapy in Patients With Congenital Heart Disease Long-Term After Initial Repair.
Ohuchi H, Kawata M, Uemura H, Akagi T, Yao A, Senzaki H, Kasahara S, Ichikawa H, Motoki H, Syoda M, Sugiyama H, Tsutsui H, Inai K, Suzuki T, Sakamoto K, Tatebe S, Ishizu T, Shiina Y, Tateno S, Miyazaki A, Toh N, Sakamoto I, Izumi C, Mizuno Y, Kato A, Sagawa K, Ochiai R, Ichida F, Kimura T, Matsuda H, Niwa K; Japanese Circulation Society Joint Working Group. Ohuchi H, et al. Among authors: motoki h. Circ J. 2022 Sep 22;86(10):1591-1690. doi: 10.1253/circj.CJ-22-0134. Epub 2022 Aug 31. Circ J. 2022. PMID: 36047167 Free article. No abstract available.
Gender difference in heart failure with preserved ejection fraction: clinical profiles, examinations, and prognosis.
Sakai T, Motoki H, Suzuki S, Fuchida A, Takeuchi T, Otagiri K, Kanai M, Kimura K, Minamisawa M, Yoshie K, Saigusa T, Ebisawa S, Okada A, Kitabayashi H, Kuwahara K. Sakai T, et al. Among authors: motoki h. Heart Vessels. 2022 Oct;37(10):1710-1718. doi: 10.1007/s00380-022-02067-2. Epub 2022 Apr 24. Heart Vessels. 2022. PMID: 35461354 Free PMC article.
Intensive exercise therapy for restenosis after superficial femoral artery stenting: the REASON randomized clinical trial.
Kato T, Miura T, Yamamoto S, Miyashita Y, Hashizume N, Shoin K, Sasaki S, Kanzaki Y, Yui H, Maruyama S, Nagae A, Sakai T, Saigusa T, Ebisawa S, Okada A, Motoki H, Ikeda U, Kuwahara K; REASON Investigators. Kato T, et al. Among authors: motoki h. Heart Vessels. 2022 Sep;37(9):1596-1603. doi: 10.1007/s00380-022-02060-9. Epub 2022 Apr 9. Heart Vessels. 2022. PMID: 35396952 Free PMC article. Clinical Trial.
129 results